CMG Pharmaceutical Statistics

Total Valuation

KOSDAQ:058820 has a market cap or net worth of KRW 294.21 billion. The enterprise value is 325.02 billion.

Market Cap	294.21B
Enterprise Value	325.02B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:058820 has 147.84 million shares outstanding. The number of shares has decreased by -15.97% in one year.

Current Share Class	147.84M
Shares Outstanding	147.84M
Shares Change (YoY)	-15.97%
Shares Change (QoQ)	+1.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	3.51%
Float	109.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.93
PB Ratio	1.44
P/TBV Ratio	1.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-33.89
EV / Sales	3.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.14

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.35.

Current Ratio	1.08
Quick Ratio	0.72
Debt / Equity	0.35
Debt / EBITDA	n/a
Debt / FCF	-1.99
Interest Coverage	-1.05

Financial Efficiency

Return on equity (ROE) is -4.79% and return on invested capital (ROIC) is -0.97%.

Return on Equity (ROE)	-4.79%
Return on Assets (ROA)	-0.87%
Return on Invested Capital (ROIC)	-0.97%
Return on Capital Employed (ROCE)	-2.05%
Revenue Per Employee	450.29M
Profits Per Employee	-43.01M
Employee Count	223
Asset Turnover	0.33
Inventory Turnover	1.73

Taxes

Income Tax	-1.88B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.98% in the last 52 weeks. The beta is 0.69, so KOSDAQ:058820's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	+7.98%
50-Day Moving Average	1,842.66
200-Day Moving Average	2,002.81
Relative Strength Index (RSI)	64.38
Average Volume (20 Days)	792,966

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:058820 had revenue of KRW 100.41 billion and -9.59 billion in losses. Loss per share was -80.13.

Revenue	100.41B
Gross Profit	56.44B
Operating Income	-4.27B
Pretax Income	-11.47B
Net Income	-9.59B
EBITDA	-1.04B
EBIT	-4.27B
Loss Per Share	-80.13

Full Income Statement

Balance Sheet

The company has 39.93 billion in cash and 70.74 billion in debt, giving a net cash position of -30.81 billion or -208.41 per share.

Cash & Cash Equivalents	39.93B
Total Debt	70.74B
Net Cash	-30.81B
Net Cash Per Share	-208.41
Equity (Book Value)	204.41B
Book Value Per Share	1,391.62
Working Capital	7.57B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.78 billion and capital expenditures -24.77 billion, giving a free cash flow of -35.55 billion.

Operating Cash Flow	-10.78B
Capital Expenditures	-24.77B
Free Cash Flow	-35.55B
FCF Per Share	-240.48

Full Cash Flow Statement

Margins

Gross margin is 56.20%, with operating and profit margins of -4.25% and -9.55%.

Gross Margin	56.20%
Operating Margin	-4.25%
Pretax Margin	-11.43%
Profit Margin	-9.55%
EBITDA Margin	-1.03%
EBIT Margin	-4.25%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:058820 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	15.97%
Shareholder Yield	15.97%
Earnings Yield	-3.26%
FCF Yield	-12.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 28, 2007. It was a forward split with a ratio of 2.

Last Split Date	Aug 28, 2007
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:058820 has an Altman Z-Score of 2 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2
Piotroski F-Score	1